CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats – CRISPR-associated endonuclease 9) is a revolutionary tool that enables gene editing with unprecedented precision and efficiency. It is based on a natural defense mechanism used by bacteria to protect themselves from viral infections.

The CRISPR-Cas9 system consists of two main components: the CRISPR guide RNA (gRNA) and the Cas9 protein. The gRNA directs the Cas9 protein to the specific site on the DNA where the desired edit is to be made. Once at the site, the Cas9 protein can cut the DNA and insert, delete or replace specific sequences of genetic information.

CRISPR-Cas9 Mechanism: How it Works

The CRISPR-Cas9 enzymatic complex performs gene editing functions by a combination of sequence homology, guide RNA and DNA repair mechanisms:

• Selection of target gene: The first step is to identify the specific gene to be edited. Once the target gene has been identified, the CRISPR-Cas9 system can be programmed to recognize the desired gene location.

• Design of guide RNA: gRNA is designed to bind with the complementary sequence of the target gene. The gRNA consists of two parts: a short RNA sequence that matches the target gene sequence and a longer scaffold sequence that helps to stabilize the gRNA-Cas9 complex.

• Formation of the CRISPR-Cas9 complex: The CRISPR-Cas9 complex is formed by combining the Cas9 enzyme with the gRNA. The Cas9 enzyme acts like molecular "scissors" that can cut the DNA at the desired location after being directed there by the gRNA.

• Targeting and binding to the DNA: After the CRISPR-Cas9 complex is introduced into the cell, the gRNA binds to the complementary sequence on the DNA strand and the Cas9 enzyme cuts both strands of the DNA molecule.

• DNA repair mechanisms: Once the DNA has been cut, the cell's natural repair mechanisms come into play. The cell may use one of two primary repair mechanisms:

  • Non-homologous end joining (NHEJ): NHEJ repairs the cut by simply rejoining the broken ends of the DNA strand. This process can introduce small errors to disrupt gene function or deletions to completely knock out a gene.
  • Homology-directed repair (HDR): HDR repairs the cut by using a template DNA molecule to replace the missing DNA sequence. This can be used to introduce specific changes or insertions into the gene's sequence to repair defects or introduce new traits.

Off-Target Effects with CRISPR-Cas9 Technology

Off-target effects can occur when the Cas9 protein cuts unintended DNA sequences that are similar to the target sequence. Several factors can influence the likelihood of off-target effects, including the specificity of the gRNA, the efficiency of the Cas9 protein and the complexity of the genome being edited.

The specificity of the gRNA is particularly important as it determines the accuracy of the targeting process. Even a single mismatch between the gRNA and the target sequence can result in off-target effects. In addition, the efficiency and expression level of the Cas9 protein can influence off-target effects. High levels of expression increase the chances of cutting unintended sequences. Finally, genome complexities like high instances of repetitive sequences or regions of variability can make it more difficult to design specific gRNAs.

Improvements made to minimize off-target effects include optimized and tested gRNAs, modified Cas9 proteins with higher specificity and using multiple gRNAs to target the same site.

Comparison of CRISPR-Cas9 Technology with Other Gene-editing Tools

CRISPR-Cas9 is not the only base editing technology available. There are several competing gene editing technologies, including:

• Zinc Finger Nucleases (ZFNs): ZFNs are engineered proteins that can be programmed to bind to specific DNA sequences and cut the DNA at that location.
• Transcription activator-like effector nucleases (TALENs): TALENs are like ZFNs in that they are proteins that can be programmed to cut specific DNA sequences.
• Homing endonucleases (HEs): HEs are naturally occurring enzymes that can recognize and cut specific DNA sequences.

Benefits Of CRISPR-Cas9 Technique

Compared to the others the CRISPR-Cas9 genome editing method offers several advantages, including:

• Efficiency: CRISPR-Cas9 is highly efficient at cutting DNA, which makes it easier to edit genes.
• Simplicity: The CRISPR-Cas9 system is easier to engineer than ZFNs or TALENs, which makes it more accessible to researchers.
• Precision: CRISPR-Cas9 can be programmed to target specific DNA sequences with high accuracy, which minimizes off-target effects.
• Flexibility: CRISPR-Cas9 gene editing is applicable to multiple species.

Future of CRISPR-Cas9 Therapeutic Applications

Leveraging CRISPR-Cas9 is relatively easy and inexpensive, making it accessible to a wide range of researchers and clinicians.  Used extensively in biotechnology, CRISPR-Cas9 introduces permanent changes to the cell genome which can be leveraged as a curative treatment for various genetic disorders.

Here are some of the CRISPR-Cas9 applications in development for therapy:

• Gene therapy: CRISPR-Cas9 can be used to correct genetic mutations for inherited genetic diseases such as cystic fibrosis and sickle cell anemia. Researchers are also exploring the use of CRISPR-Cas9 to treat acquired genetic diseases such as cancer.
• Cell therapy: Another application of CRISPR-Cas9 is cell modification for transplantation into patients. For example, it can be used to modify patient T cells to better target cancer cells or modify stem cells for use in regenerative medicine.
• Genome-wide screens: CRISPR-Cas9 can help screen the entire genome to identify new drug targets and pathways for therapeutic intervention.
• Antiviral therapy: CRISPR-Cas9 can potentially target and eliminate viral infections. It enables genome editing of viruses to prevent them from replicating. It can also help modify human cells to make them more resistant to viral infections.
• Precision medicine: CRISPR-Cas9 gene editing offers the potential for developing personalized therapies that are tailored to an individual's genetic makeup. This may help ensure that patients receive the most effective treatment with the fewest side effects.
• Drug development: CRISPR-Cas9 can be used to develop model systems for safety testing.

CRISPR Cures on the Horizon: Danaher and IGI Launch Groundbreaking Collaboration

A beacon of hope for rare and other diseases

Danaher Corporation and the Innovative Genomics Institute (IGI) have joined forces to create the Danaher-IGI Beacon for CRISPR Cures. This collaborative center marks a significant step forward in the fight against numerous diseases, aiming to utilize CRISPR gene editing for permanent solutions.

CRISPR pioneerDr. Jennifer Doudna leads the charge alongside Fyodor Urnov and Brad Ringeisen from IGI. Danaher brings its extensive expertise in life sciences and diagnostics, offering technologies and solutions for CRISPR therapy manufacturing.

Beyond individual diseases

This Beacon initiative transcends specific diagnoses. The goal is to establish a standardized approach for CRISPR-based therapies, applicable to hundreds of diseases. This blueprint will pave the way for faster development and delivery of life-changing treatments to patients.

recent-articles